• Users Online: 277
  • Print this page
  • Email this page
CASE REPORT
Year : 2023  |  Volume : 3  |  Issue : 1  |  Page : 118-120

Bilateral optic neuritis as a presentation of myelin oligodendrocyte glycoprotein antibody associated disease in a child


Department of Pediatric Ophthalmology and Strabismology, Sankara Eye Hospital, Coimbatore, Tamil Nadu, India

Correspondence Address:
Sai Lakshmi Raghavan
Department of Pediatric Ophthalmology and Strabismology, Sankara Eye Hospital, Coimbatore - 641 035, Tamil Nadu
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijo.IJO_1803_22

Rights and Permissions

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), although rare, is now recognized as a distinct demyelinating disorder. The entity differs from multiple sclerosis and neuromyelitis optica spectrum disorder in terms of clinical presentation, radiodiagnostic features, and prognosis. Here, we present a 5-year-old female who presented with bilateral, painless loss of vision since 3 days. There was optic nerve enhancement, but no brain parenchymal lesions. She tested negative for Aquaporin-4 antibodies, and CSF analysis showed no oligoclonal bands. Serum analysis revealed positivity for myelin oligodendrocyte antibodies. There was full visual recovery on treatment with systemic steroids. The report highlights the need for testing for MOG–IgG antibodies, especially in children with bilateral optic neuritis. It is essential to differentiate the entity from other demyelinating conditions. The prognosis is usually benign.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed156    
    Printed4    
    Emailed0    
    PDF Downloaded10    
    Comments [Add]    

Recommend this journal